[go: up one dir, main page]

AU4767896A - Human immunodeficiency virus transcription inhibitors and methods of their use - Google Patents

Human immunodeficiency virus transcription inhibitors and methods of their use

Info

Publication number
AU4767896A
AU4767896A AU47678/96A AU4767896A AU4767896A AU 4767896 A AU4767896 A AU 4767896A AU 47678/96 A AU47678/96 A AU 47678/96A AU 4767896 A AU4767896 A AU 4767896A AU 4767896 A AU4767896 A AU 4767896A
Authority
AU
Australia
Prior art keywords
methods
immunodeficiency virus
human immunodeficiency
transcription inhibitors
virus transcription
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47678/96A
Inventor
Sudhir Agrawal
Asya Levina
Valeri Metelev
Jamal Temsamani
Paul Zamecnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Worcester Foundation for Biomedical Research
Aceragen Inc
Original Assignee
Worcester Foundation for Biomedical Research
Hybridon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Worcester Foundation for Biomedical Research, Hybridon Inc filed Critical Worcester Foundation for Biomedical Research
Publication of AU4767896A publication Critical patent/AU4767896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU47678/96A 1995-01-30 1996-01-24 Human immunodeficiency virus transcription inhibitors and methods of their use Abandoned AU4767896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38065095A 1995-01-30 1995-01-30
US380650 1995-01-30
PCT/US1996/001008 WO1996023878A1 (en) 1995-01-30 1996-01-24 Human immunodeficiency virus transcription inhibitors and methods of their use

Publications (1)

Publication Number Publication Date
AU4767896A true AU4767896A (en) 1996-08-21

Family

ID=23501985

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47678/96A Abandoned AU4767896A (en) 1995-01-30 1996-01-24 Human immunodeficiency virus transcription inhibitors and methods of their use

Country Status (4)

Country Link
EP (1) EP0807172A1 (en)
AU (1) AU4767896A (en)
CA (1) CA2211877A1 (en)
WO (1) WO1996023878A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression
US5919677A (en) * 1997-05-09 1999-07-06 The Research Foundation Of State University Of New York Eukaryotic and retroviral antisense initiator elements
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2
US20130130231A1 (en) * 2002-11-26 2013-05-23 Isaac Bentwich Bioinformatically detectable group of novel viral regulatory genes and uses thereof
US20140072961A1 (en) * 2012-07-11 2014-03-13 University of Nevada, Las Vegas Method of Genome Surgery with Paired, Permeant Endonuclease Excision
WO2022266414A1 (en) 2021-06-18 2022-12-22 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing ifnar1 expression
WO2022266415A1 (en) * 2021-06-18 2022-12-22 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing ifnar1 expression

Also Published As

Publication number Publication date
CA2211877A1 (en) 1996-08-08
WO1996023878A1 (en) 1996-08-08
EP0807172A1 (en) 1997-11-19

Similar Documents

Publication Publication Date Title
AU5793396A (en) Human interferon tau compositions and methods of use
AU1273397A (en) Non-pneumatic tourniquet and method of use
AU1326895A (en) Methods of making and using ultrasonic handpiece
AU2071097A (en) Cannula and method of manufacture and use
AU6942498A (en) Voice activated locomotor device and method of use
AU7250098A (en) Anastomosis system and method of use
AU5171896A (en) Adjustable blood pressure cuff and method of using same
AU2478595A (en) Expanding dental implant and method of use
AU7236596A (en) Transdermal administration of ropinirole and analogs thereof
AU4859296A (en) Improved fiber filter and methods of use thereof
AU5669494A (en) Human homolog of the e-cadherin gene and methods based thereon
ZA967654B (en) Electrodes and methods of preparation thereof
AU5326496A (en) Acoustic imaging catheter and method of operation
AU4028895A (en) Vaccine and treatment method of Human Immunodeficiency Virus
AU7621496A (en) Microsensor and use of such microsensor
AU1842597A (en) Human rad50 and septin-2 genes and methods of use
AU7254894A (en) Activated human factor viii and method of preparation
AU7090196A (en) Inhibitors of integrin receptors and their therapeutical uses
AU7065694A (en) Catheter and method of use thereof
AU6256396A (en) Dental adhesive device and method of making
AU6040296A (en) Methods of inducing bef-1 transcription factor
AU6104896A (en) Therapeutic microdevices and methods of making and using sam e
AU4767896A (en) Human immunodeficiency virus transcription inhibitors and methods of their use
AU3118297A (en) Sok-1 and methods of use
AU1466097A (en) Protected biopolymers for oral administration and methods of using same